Skip to main content

Table 3 Model 2 random intercept and country-level covariates

From: Individual well-being and national determinants of screening mammography among women over fifty

 

CASP

EURO-Dr

SHr

 

OR (95%CI)

ICC

OR (95%CI)

ICC

OR (95%CI)

ICC

THE (% of GDP)

1.16* (1.03–1.30)

0.09

1.28** (1.09–1.49)

0.15

1.27** (1.09–1.48)

0.15

GHE (% of GDP)

1.21*** (1.08–1.36)

0.07

1.31*** (1.11–1.53)

0.14

1.30** (1.11–1.52)

0.14

Country programs—Regional

3.43** (1.54–7.65)

0.07

7.12*** (2.85–17.79)

0.10

6.99*** (2.85–17.11)

0.10

Country programs—Organized

3.12*** (1.69–5.72)

0.07

5.92*** (3.06–11.45)

0.10

5.88*** (3.08–11.22)

0.10

  1. Total health expenditure as a proportion of GDP (THE), government health expenditure as a proportion of GDP (GHE) and Country breast cancer screening program strategy (Country programs: Opportunistic (Base), Regional, Organized). For each of the exposure models the left columns show Odds Ratios and 95% Confidence Intervals for each of the regression models. The right columns show the adjusted intraclass correlation (ICC) of each of the regression models. All models were adjusted for individual-level covariates and exposure variables CASP, EURO-Dr, and SHr. For the full models see Supplementary Table 5
  2. *p < 0.05
  3. **p < 0.01
  4. ***p < 0.001
Back to article page

International Journal for Equity in Health

ISSN: 1475-9276

Contact us